These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8378512)

  • 1. Differences in adverse drug reactions in phase III and phase IV of the drug evaluation process.
    Linden M
    Psychopharmacol Bull; 1993; 29(1):51-6. PubMed ID: 8378512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect and efficacy--on the function of models in controlled phase III trials and the need for prospective pharmacoepidemiological studies.
    Winterer G; Herrmann WM
    Pharmacopsychiatry; 1996 Jul; 29(4):135-41; discussion 142-3. PubMed ID: 8858712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical tolerability profile of alendronate.
    Watts N; Freedholm D; Daifotis A
    Int J Clin Pract Suppl; 1999 Apr; 101():51-61. PubMed ID: 12669741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the implementation of drug utilization observation (DUO) studies in psychopharmacological therapy. The "Phase IV Research" Task-Force of the Association for Neuropsychopharmacology and Pharmacopsychiatry (AGNP).
    Linden M; Baier D; Beitinger H; Kohnen R; Osterheider M; Philipp M; Reimitz DE; Schaaf B; Weber HJ
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):65-70. PubMed ID: 9035231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
    André FE; Foulkes MA
    Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug safety in psychiatry--an objective for drug monitoring in phase IV.
    Schmidt LG; Müller-Oerlinghausen B
    Pharmacopsychiatry; 1984 Sep; 17(5):152-6. PubMed ID: 6494244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethics problems in phase IV of drug studies].
    Traversa G; Bignami G
    Ann Ist Super Sanita; 1998; 34(2):203-8. PubMed ID: 9810742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
    Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing surveillance versus clinical trials: which benefits the patient?
    Lawson DH
    Cardiology; 1994; 85 Suppl 1():18-23. PubMed ID: 7743530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The decisive steps cost billions. Extensive studies provide answers for many questions].
    Wallström A; Rosén A; Keisu M
    Lakartidningen; 1997 Jul; 94(30-31):2653-7. PubMed ID: 9273428
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial design in metastatic breast cancer: a commentary.
    Levine M
    Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality studies and the effectiveness of drugs in long-term treatment.
    Ahrens B
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):57-61. PubMed ID: 9035229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
    Bender S; Grohmann R; Engel RR; Degner D; Dittmann-Balcar A; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IV research and drug utilization observation studies.
    Linden M
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):1-3. PubMed ID: 9035221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.